Minfei Wu

738 total citations
17 papers, 549 citations indexed

About

Minfei Wu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Minfei Wu has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Cancer Research. Recurrent topics in Minfei Wu's work include Spinal Cord Injury Research (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Minfei Wu is often cited by papers focused on Spinal Cord Injury Research (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Minfei Wu collaborates with scholars based in China. Minfei Wu's co-authors include Yang Wang, Guanjie Zhao, Jianhang Jiao, Pengfei Ren, Yuhua Chen, Wei Liu, Hua Li, Jiao Meng, Liangjun Zhang and Fangfang Bi and has published in prestigious journals such as Chemical Engineering Journal, Frontiers in Immunology and Journal of Cellular Biochemistry.

In The Last Decade

Minfei Wu

16 papers receiving 545 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Minfei Wu 345 92 74 69 63 17 549
Weibin Lin 229 0.7× 83 0.9× 91 1.2× 57 0.8× 56 0.9× 24 555
Min‐Jae Jo 333 1.0× 97 1.1× 39 0.5× 74 1.1× 48 0.8× 12 601
Maoqiang Li 396 1.1× 174 1.9× 67 0.9× 114 1.7× 77 1.2× 36 677
Mingyan Guo 260 0.8× 61 0.7× 64 0.9× 61 0.9× 131 2.1× 32 706
Bingwei Li 181 0.5× 79 0.9× 39 0.5× 103 1.5× 47 0.7× 47 512
Ke Ma 322 0.9× 121 1.3× 84 1.1× 57 0.8× 29 0.5× 33 977
Xinwei He 202 0.6× 48 0.5× 73 1.0× 85 1.2× 98 1.6× 36 584
Heyangzi Li 328 1.0× 163 1.8× 74 1.0× 69 1.0× 40 0.6× 17 653
Hanbin Wang 228 0.7× 32 0.3× 59 0.8× 72 1.0× 80 1.3× 54 582
Haijun Bao 320 0.9× 40 0.4× 42 0.6× 71 1.0× 55 0.9× 20 583

Countries citing papers authored by Minfei Wu

Since Specialization
Citations

This map shows the geographic impact of Minfei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minfei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minfei Wu more than expected).

Fields of papers citing papers by Minfei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minfei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minfei Wu. The network helps show where Minfei Wu may publish in the future.

Co-authorship network of co-authors of Minfei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Minfei Wu. A scholar is included among the top collaborators of Minfei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minfei Wu. Minfei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Han, Zhonghan Wang, Yang Wang, et al.. (2025). Dual-functional improvement of vascularization and bone formation of complementary PRP-based gel scaffold. Chemical Engineering Journal. 505. 159512–159512. 2 indexed citations
2.
Yu, Tong, et al.. (2025). CAR‐T cells in the treatment of multiple myeloma: an encouraging cell therapy. Frontiers in Immunology. 16. 1499590–1499590. 3 indexed citations
3.
4.
Yu, Tong, et al.. (2024). Exosome-mediated repair of spinal cord injury: a promising therapeutic strategy. Stem Cell Research & Therapy. 15(1). 6–6. 29 indexed citations
5.
Zhang, Han, Zhonghan Wang, Yang Wang, et al.. (2022). Biomaterials for Interbody Fusion in Bone Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 10. 900992–900992. 21 indexed citations
6.
Feng, Guang, et al.. (2020). MiR‐140‐5p promotes osteogenic differentiation of mouse embryonic bone marrow mesenchymal stem cells and post‐fracture healing of mice. Cell Biochemistry and Function. 38(8). 1152–1160. 12 indexed citations
7.
Jiao, Jianhang, et al.. (2020). Necrosulfonamide Ameliorates Neurological Impairment in Spinal Cord Injury by Improving Antioxidative Capacity. Frontiers in Pharmacology. 10. 1538–1538. 41 indexed citations
8.
Jiao, Jianhang, Guanjie Zhao, Yang Wang, Pengfei Ren, & Minfei Wu. (2020). MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury. Frontiers in Molecular Biosciences. 7. 37–37. 78 indexed citations
9.
Wu, Minfei, et al.. (2020). Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p. International Journal of Molecular Medicine. 46(3). 1029–1038. 17 indexed citations
10.
Wang, Yang, et al.. (2019). RIP3 inhibition protects locomotion function through ameliorating mitochondrial antioxidative capacity after spinal cord injury. Biomedicine & Pharmacotherapy. 116. 109019–109019. 21 indexed citations
11.
Zhao, Xin, Ronghang Li, Qian Wang, Minfei Wu, & Yanbing Wang. (2019). Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma. Diagnostic Pathology. 14(1). 118–118. 11 indexed citations
12.
Wang, Yang, et al.. (2019). Upregulation of miRNA‐223‐3p ameliorates RIP3‐mediated necroptosis and inflammatory responses via targeting RIP3 after spinal cord injury. Journal of Cellular Biochemistry. 120(7). 11582–11592. 27 indexed citations
13.
Liu, Wei, Yuhua Chen, Jiao Meng, et al.. (2018). Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo. Journal of Neuroinflammation. 15(1). 48–48. 155 indexed citations
14.
Zhao, Guanjie, Minfei Wu, Xiaofeng Wang, Zhenwu Du, & Guizhen Zhang. (2017). Effect of FABP5 gene silencing on the proliferation, apoptosis and invasion of human gastric SGC-7901 cancer cells. Oncology Letters. 14(4). 4772–4778. 21 indexed citations
15.
Zhang, Shuquan, Minfei Wu, Chuangang Peng, Guanjie Zhao, & Rui Gu. (2017). GFAP expression in injured astrocytes in rats. Experimental and Therapeutic Medicine. 14(3). 1905–1908. 87 indexed citations
16.
Gu, Rui, Minfei Wu, Jinlan Jiang, et al.. (2015). Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro. Tumor Biology. 37(1). 353–360. 6 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weibin Lin Breakdown of academic impact, for papers by Min‐Jae Jo Breakdown of academic impact, for papers by Maoqiang Li Breakdown of academic impact, for papers by Mingyan Guo Breakdown of academic impact, for papers by Bingwei Li Breakdown of academic impact, for papers by Ke Ma Breakdown of academic impact, for papers by Xinwei He Breakdown of academic impact, for papers by Heyangzi Li Breakdown of academic impact, for papers by Hanbin Wang Breakdown of academic impact, for papers by Haijun Bao
Rankless by CCL
2026